IL6 and osteoarthritis: Improved osteoarthritis pain (WOMAC score ↓ 35%) Elevated levels of SCFAs (butyric acid ↑42%) Reduced systemic inflammation (IL-6 ↓29%, CRP ↓26%) Reduced risk of chronic pain 33% with long-term intake